We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Planned action next month threatens to cause ‘biggest disruption from NHS walkouts so far’
Swiss group rethinks NHS collaboration after low take-up of treatment during rollout via GPs
After decades caring for people at their most vulnerable, her experience maps the path the UK has taken
It’s time to emphasise prevention over cure. We’re currently scrimping on parks and pools to spend more on diabetes
The maker of Wegovy and Ozempic generated $2.4bn in sales from weight-loss treatments last year
The US retailer has been moving into healthcare for older people as it seeks to expand beyond its core business
Fifty organisations form coalition to counter dangerous falsehoods and rebuild trust in science
Pharma groups and legal experts fear fallout if Texas court overturns regulatory approval after 23 years
Data businesses and medical equipment suppliers are riding long-term trends such as ageing
Health department says industry’s plan, published ahead of talks, would limit access to new medicines
Occupational therapists may provide one practical solution to those struggling with their physical or mental health
UK pharma industry claims that de facto tax will hurt research and development investment
Specialist drugs sold by Big Pharma are so expensive that many patients are being excluded
Three ways to tackle the vast disparities in A&E waits and delayed routine operations
Drugmaker taken to court by public interest group for abusing market position and profiteering
Regulatory restrictions hamper companies despite recovery in semiconductor supply, says chief
Money problems experienced by elderly customers can be red flags for families and institutions alike
As a patient and Number 10 adviser, Camilla Cavendish has witnessed the service’s struggles at first hand. Here she charts a way to safeguard its future
A push to reduce healthcare spending and increase efficiency is leading to consolidation
Cash-strapped local authorities seek savings after high cost of battling Covid
Investment in psychological support fails to keep pace with rising demand, with acute delays for eating disorder sufferers
Pharmacy chain hopes deal for primary care centre operator will speed up push into other parts of US healthcare
The FT examines the causes and effects of an increasing global resistance to antibiotics: from the pressures doctors are under to prescribe them, to what new treatments are currently in the pipeline, as well as what role can the consumer play in reducing antibiotic use in the food chain
New ways of working are vital but ultimately the UK health service simply needs more cash, experts say
The UK’s national health system is showing signs of frailty as it nears its 75th birthday
UK Edition
